I. Intangiriro
Fosifolipide nicyiciro cya lipide nibintu byingenzi bigize selile kandi bifite imiterere yihariye igizwe numutwe wa hydrophilique numurizo wa hydrophobique. Imiterere ya amphipathic ya fosifolipide ibafasha gukora lipide bilayers, aribwo shingiro rya selile. Fosifolipide igizwe numugongo wa glycerol, iminyururu ibiri ya aside irike, hamwe nitsinda rya fosifate, hamwe nitsinda ritandukanye ryometse kuri fosifate. Iyi miterere itanga fosifolipide ubushobozi bwo kwishyira hamwe muri lipide bilayers na viticles, zikaba ari ingenzi cyane mubusugire n'imikorere yibinyabuzima.
Fosifolipide igira uruhare runini mu nganda zitandukanye bitewe n'imiterere yihariye, harimo emulisile, solubilisation, n'ingaruka zihamye. Mu nganda z’ibiribwa, fosifolipide ikoreshwa nka emulisiferi na stabilisateur mu biribwa bitunganijwe, hamwe n’ibigize intungamubiri bitewe n’ingaruka zishobora guteza ubuzima. Mu kwisiga, fosifolipide ikoreshwa muburyo bwo kwigana no gutanga amazi, no kuzamura itangwa ryibintu bikora mubuvuzi bwuruhu nibicuruzwa byawe bwite. Byongeye kandi, fosifolipide ifite akamaro gakomeye muri farumasi, cyane cyane muri sisitemu yo gutanga imiti no kuyikora, bitewe nubushobozi bwabo bwo gukusanya no kugeza imiti ku ntego runaka mu mubiri.
II. Uruhare rwa Fosifolipide mu biryo
A. Emulisation no gutuza ibintu
Fosifolipide ikora nka emulisiferi yinganda mu biribwa kubera imiterere ya amphifilique. Ibi bibafasha gukorana n'amazi n'amavuta, bigatuma bakora neza muguhagarika emulisiyo, nka mayoneze, kwambara salade, nibikomoka ku mata atandukanye. Umutwe wa hydrophilique ya molekile ya fosifolipide ukurura amazi, mugihe imirizo ya hydrophobique yangwa nayo, bigatuma habaho intera ihamye hagati yamavuta namazi. Uyu mutungo ufasha gukumira gutandukana no gukomeza gukwirakwiza ibintu bimwe mubicuruzwa byibiribwa.
B. Koresha mugutunganya ibiryo no kubibyaza umusaruro
Fosifolipide ikoreshwa mugutunganya ibiryo kubikorwa byayo, harimo nubushobozi bwabo bwo guhindura imiterere, kunoza ububobere, no gutanga ituze kubiribwa. Bakunze gukoreshwa mugukora ibicuruzwa bitetse, ibirungo, nibikomoka ku mata kugirango bazamure ubuzima bwiza nubuzima bwibicuruzwa byanyuma. Byongeye kandi, fosifolipide ikoreshwa nk'imiti igabanya ubukana mu gutunganya inyama, inkoko, n'ibikomoka ku nyanja.
C. Inyungu zubuzima nibisabwa nimirire
Fosifolipide igira uruhare mu mirire y’ibiribwa nkibigize ibintu byinshi biva mu mirire, nk'amagi, soya, n'ibikomoka ku mata. Barazwi kubera inyungu zishobora guteza ubuzima, harimo uruhare rwabo mumiterere yimikorere nimikorere, hamwe nubushobozi bwabo bwo gushyigikira ubuzima bwubwonko nibikorwa byubwenge. Fosifolipide nayo ikorerwa ubushakashatsi kubushobozi bwayo bwo kuzamura metabolisme ya lipide nubuzima bwumutima.
III. Gukoresha Fosifolipide mu mavuta yo kwisiga
A. Ingaruka zo gukurura no gutanga amazi
Fosifolipide ikoreshwa cyane mumavuta yo kwisiga hamwe nibicuruzwa byumuntu ku giti cye kugirango bigire ingaruka nziza. Bitewe na amphiphilique, fosifolipide irashobora gukora emulisiyo ihamye, bigatuma amazi nibigize amavuta bivangwa, bikavamo amavuta n'amavuta yo kwisiga hamwe nuburyo bworoshye, bumwe. Byongeye kandi, imiterere yihariye ya fosifolipide ibafasha kwigana inzitizi ya lipide isanzwe yuruhu, igahindura neza uruhu kandi ikarinda gutakaza amazi, ifasha mukubungabunga uruhu no kwirinda gukama.
Fosifolipide nka lecithine yakoreshejwe nka emulisiferi na moisturizer mu bicuruzwa bitandukanye byo kwisiga no kuvura uruhu, harimo amavuta, amavuta yo kwisiga, serumu, hamwe nizuba. Ubushobozi bwabo bwo kunoza imiterere, ibyiyumvo, hamwe nubushuhe bwibi bicuruzwa bituma bakora ibintu byingenzi mubikorwa byo kwisiga.
B. Gutezimbere itangwa ryibintu bikora
Fosifolipide igira uruhare runini mukuzamura itangwa ryibintu bikora muburyo bwo kwisiga no kuvura uruhu. Ubushobozi bwabo bwo gukora liposomes, viticles zigizwe na bilayeri ya fosifolipide, ituma habaho gukingira no kurinda ibintu bikora, nka vitamine, antioxydants, nibindi bintu byingirakamaro. Uku gufunga bifasha kunoza ituze, bioavailability, hamwe nogutanga kugezwaho ibyo bintu bifatika kuruhu, bikongera imbaraga mubikorwa byo kwisiga no kuvura uruhu.
Byongeye kandi, sisitemu yo gutanga fosifolipide yakoreshejwe kugirango ikemure ibibazo byo gutanga hydrophobique na hydrophilique ikora, bigatuma iba ibintu byinshi bitandukanye byo kwisiga. Liposomal formulaire irimo fosifolipide yakoreshejwe cyane mubirwanya gusaza, kubushuhe, no gusana uruhu, aho bishobora gutanga ibikoresho bikora neza kurwego rwuruhu rugenewe.
C. Uruhare mu kwita ku ruhu n'ibicuruzwa byita ku muntu
Fosifolipide igira uruhare runini mu kwita ku ruhu n’ibicuruzwa byita ku muntu, bigira uruhare mu mikorere yabyo no gukora neza. Usibye kuba emulisitiya, itanga amazi, hamwe niyongera-kubyara, fosifolipide inatanga inyungu nko gutunganya uruhu, kurinda, no gusana. Izi molekile zinyuranye zirashobora gufasha kunoza ubunararibonye bwimyumvire no gukora ibicuruzwa byo kwisiga, bikabigira ibintu bizwi muburyo bwo kuvura uruhu.
Kwinjiza fosifolipide mu kwita ku ruhu n’ibicuruzwa byita ku muntu birenze ibirenze ibishishwa hamwe n’amavuta, kuko bikoreshwa no mu koza, izuba, izuba, no kwisiga. Kamere yabo myinshi ibemerera gukemura ibibazo bitandukanye byuruhu no kwita kumisatsi, bitanga inyungu zo kwisiga no kuvura kubakoresha.
IV. Gukoresha Fosifolipide muri Farumasi
A. Gutanga ibiyobyabwenge no kubitegura
Fosifolipide igira uruhare runini mugutanga imiti no kuyitunganya bitewe na kamere ya amphifilique, ibafasha gukora lipide bilayers na viticles zishobora gukwirakwiza imiti ya hydrophobi na hydrophilique. Uyu mutungo utuma fosifolipide itera imbaraga zo gukemura, gutekana, hamwe na bioavailable yimiti idashonga, bikongerera ubushobozi bwo gukoresha imiti. Sisitemu yo gutanga imiti ishingiye kuri fosifolipide irashobora kandi kurinda ibiyobyabwenge kwangirika, kugenzura ibyerekeranye no kurekura, no kwibasira ingirabuzimafatizo cyangwa ingirabuzimafatizo, bikagira uruhare mu kuzamura ibiyobyabwenge no kugabanya ingaruka mbi.
Ubushobozi bwa fosifolipide yo kwibumbira hamwe, nka liposomes na micelles, bwakoreshejwe mugutezimbere imiti itandukanye yimiti, harimo umunwa, umubyeyi, nuburyo bwa dosiye. Amavuta ashingiye kuri Lipide, nka emulsiyo, nanoparticles ikomeye ya lipide, hamwe na sisitemu yo gutanga imiti yonyine, akenshi iba irimo fosifolipide kugirango ikemure ibibazo bifitanye isano no kwikuramo ibiyobyabwenge no kuyikuramo, amaherezo bikazamura imiti ivura ibicuruzwa bivura imiti.
B. Uburyo bwo gutanga imiti ya Liposomal
Sisitemu yo gutanga imiti ya Liposomal ni urugero rwerekana uburyo fosifolipide ikoreshwa mugukoresha imiti. Liposomes, igizwe na biosiferi ya fosifolipide, ifite ubushobozi bwo gukusanya ibiyobyabwenge mu mazi y’amazi cyangwa mu mazi ya lipide, bitanga ibidukikije bikingira no kugenzura irekurwa ry’ibiyobyabwenge. Ubu buryo bwo gutanga ibiyobyabwenge burashobora guhuzwa nogutezimbere itangwa ryubwoko butandukanye bwibiyobyabwenge, harimo imiti ya chimiotherapeutique, antibiotike, ninkingo, bitanga inyungu nkigihe cyo kuzenguruka igihe kirekire, kugabanya uburozi, no kongera intego yibice byingirangingo cyangwa selile.
Ubwinshi bwa liposomes butuma uhindura ingano, ingano, hamwe nubutaka bwo hejuru kugirango hongerwe imiti, ituze, nogukwirakwiza ingirangingo. Ihinduka ryatumye habaho iterambere rya liposomal yemewe nubuvuzi butandukanye bwo kuvura, bishimangira akamaro ka fosifolipide mugutezimbere ikoranabuhanga ryo gutanga ibiyobyabwenge.
C. Ibishoboka mubushakashatsi mubuvuzi no kuvura
Fosifolipide ifite ubushobozi bwo gusaba mubushakashatsi bwubuvuzi no kuvura birenze uburyo bwo gutanga imiti isanzwe. Ubushobozi bwabo bwo gukorana na selile hamwe no guhindura imikorere ya selile bitanga amahirwe yo gutegura ingamba zo kuvura udushya. Ubushakashatsi bwakozwe na fosifolipide bwakozweho ubushakashatsi ku bushobozi bafite bwo guhitamo inzira zo mu nda, guhindura imiterere ya gene, no kongera imikorere y’imiti itandukanye ivura, byerekana uburyo bwagutse mu bice nko kuvura gene, ubuvuzi bushya, no kuvura kanseri.
Byongeye kandi, fosifolipide yashakishijwe ku ruhare rwayo mu guteza imbere gusana ingirabuzima fatizo no kuvugurura ibintu, kwerekana ubushobozi bwo gukira ibikomere, ubwubatsi bw’imitsi, n’ubuvuzi bushya. Ubushobozi bwabo bwo kwigana uturemangingo karemano no gukorana na sisitemu y'ibinyabuzima bituma fosifolipide iba inzira nziza yo guteza imbere ubushakashatsi mubuvuzi no kuvura.
V. Ibibazo hamwe nicyerekezo kizaza
A. Ibitekerezo byigenga nibibazo byumutekano
Ikoreshwa rya fosifolipide mu biribwa, kwisiga, no mu miti yerekana ibitekerezo bitandukanye bijyanye n’umutekano hamwe n’umutekano. Mu nganda zibiribwa, fosifolipide ikoreshwa nka emulisiferi, stabilisateur, hamwe na sisitemu yo gutanga kubintu bikora. Inzego zishinzwe kugenzura ibikorwa, nk'ubuyobozi bushinzwe ibiryo n'ibiyobyabwenge (FDA) muri Amerika ndetse n’ikigo cy’Uburayi gishinzwe umutekano w’ibiribwa (EFSA) mu Burayi, kigenzura umutekano n’ikirango cy’ibiribwa birimo fosifolipide. Isuzuma ry’umutekano ni ngombwa kugira ngo inyongeramusaruro zishingiye kuri fosifolipide zifite umutekano ku biribwa kandi zubahirize amabwiriza yashyizweho.
Mu nganda zo kwisiga, fosifolipide ikoreshwa mubuvuzi bwuruhu, gutunganya umusatsi, hamwe nibicuruzwa byita kumuntu kubintu byangiza, bitanga amazi, hamwe nimbogamizi zuruhu. Inzego zishinzwe kugenzura ibintu, nk'Umuryango w’ubumwe bw’ibihugu by’Uburayi n’amavuta yo kwisiga hamwe n’ikigo cy’Amerika gishinzwe ibiryo n’ibiyobyabwenge (FDA), gikurikirana umutekano n’ikirango cy’ibintu byo kwisiga birimo fosifolipide kugira ngo birengere abaguzi. Isuzuma ryumutekano hamwe nubushakashatsi bwuburozi bukorwa kugirango hamenyekane imiterere yumutekano wibintu byo kwisiga bya fosifolipide.
Mu rwego rwa farumasi, umutekano n’ibitekerezo bya fosifolipide bikubiyemo gukoresha muri sisitemu yo gutanga imiti, imiti ya liposomal, hamwe n’ibikoresho bikoresha imiti. Inzego zishinzwe kugenzura ibikorwa, nka FDA n’ikigo cy’ubuvuzi cy’uburayi (EMA), zisuzuma umutekano, imikorere, n’ubuziranenge bw’ibicuruzwa bikoreshwa mu bya farumasi birimo fosifolipide binyuze mu buryo bukomeye bwo gusuzuma no kwa muganga. Impungenge z'umutekano zijyanye na fosifolipide muri farumasi ahanini zishingiye ku burozi bushobora kuba uburozi, ubudahangarwa bw'umubiri, no guhuza n'ibiyobyabwenge.
B. Ibigenda bigaragara no guhanga udushya
Ikoreshwa rya fosifolipide mubiribwa, kwisiga, hamwe na farumasi bigenda byiyongera kandi bigezweho. Mu nganda z’ibiribwa, ikoreshwa rya fosifolipide nka emulisiferi na stabilisateur bigenda byiyongera, bitewe n’ubushake bugenda bukenera ibirango bisukuye hamwe n’ibiribwa bisanzwe. Ubuhanga bugezweho, nka nanoemuliyoni ihagarikwa na fosifolipide, burimo gushakishwa kugirango hongerwe imbaraga hamwe na bioavailable yibigize ibiryo bikora, nka bioactive compound na vitamine.
Mu nganda zo kwisiga, ikoreshwa rya fosifolipide muburyo bwo kuvura uruhu rwateye imbere ni inzira igaragara, hibandwa kuri sisitemu yo gutanga lipide ishingiye kubintu bikora no gusana inzitizi zuruhu. Imikorere ikubiyemo fosifolipide ishingiye kuri nanocarrier, nka liposomes hamwe na lipide ya nanostructures itwara lipide (NLCs), itezimbere imikorere nogutanga ibikoresho byo kwisiga, bigira uruhare muguhanga udushya mu kurwanya gusaza, kurinda izuba, nibicuruzwa byita kuruhu byihariye.
Mu rwego rwa farumasi, inzira zigaragara mu gutanga imiti ishingiye kuri fosifolipide ikubiyemo imiti yihariye, imiti igamije, hamwe na sisitemu yo gutanga imiti. Iterambere rishingiye kuri lipide, harimo na Hybrid lipid-polymer nanoparticles hamwe n’ibiyobyabwenge bishingiye kuri lipide, birategurwa hagamijwe kunoza itangwa ry’ubuvuzi bushya ndetse n’ubuvuzi buriho, bikemura ibibazo bijyanye no gukemura ibibazo by’ibiyobyabwenge, umutekano, hamwe n’urubuga rwihariye.
C. Ibishoboka mubufatanye bwinganda n'amahirwe yo kwiteza imbere
Ubwinshi bwa fosifolipide butanga amahirwe yo gukorana n’inganda no guteza imbere ibicuruzwa bishya mu masangano y’ibiribwa, amavuta yo kwisiga, n’imiti. Ubufatanye bw’inganda bushobora koroshya kungurana ubumenyi, ikoranabuhanga, hamwe nuburyo bwiza bujyanye no gukoresha fosifolipide mu nzego zitandukanye. Kurugero, ubuhanga muri sisitemu yo gutanga lipide ituruka mu nganda zimiti irashobora gukoreshwa kugirango hongerwe igishushanyo mbonera n’imikorere y’ibikoresho bishingiye kuri lipide mu biribwa no kwisiga.
Byongeye kandi, guhuza ibiryo, kwisiga, hamwe n’imiti biganisha ku iterambere ryibicuruzwa byinshi bikemura ibibazo byubuzima, ubuzima bwiza, nubwiza bukenewe. Kurugero, intungamubiri na cosmeceuticals zirimo fosifolipide bigenda bigaragara nkibikorwa byubufatanye bwinganda, bitanga ibisubizo bishya biteza imbere inyungu zimbere mu gihugu no hanze. Ubu bufatanye kandi butanga amahirwe yo gukora ubushakashatsi nibikorwa byiterambere bigamije gushakisha uburyo bushobora gukoreshwa hamwe nuburyo bushya bwa fosifolipide mugukora ibicuruzwa byinshi.
VI. Umwanzuro
A. Ongera usubiremo ibintu byinshi nibisobanuro bya fosifolipide
Fosifolipide igira uruhare runini mu nganda zinyuranye, itanga uburyo butandukanye bwo gukoresha ibiryo, amavuta yo kwisiga, hamwe n’imiti. Imiterere yihariye yimiti, ikubiyemo uturere twa hydrophilique na hydrophobique, ibafasha gukora nka emulisiferi, stabilisateur, hamwe na sisitemu yo gutanga kubintu bikora. Mu nganda z’ibiribwa, fosifolipide igira uruhare mu gutuza no gutunganya ibiryo bitunganijwe, mu gihe mu kwisiga, bitanga ibintu bitanga amazi, bitera imbaraga, kandi byongera inzitizi mu bicuruzwa byita ku ruhu. Byongeye kandi, uruganda rwa farumasi rukoresha fosifolipide muri sisitemu yo gutanga imiti, imiti ya liposomal, kandi nkibikoresho bya farumasi bitewe nubushobozi bwabo bwo kongera bioavailability no kugena ahantu runaka ibikorwa.
B. Ibyerekeranye nubushakashatsi buzaza hamwe ninganda zikoreshwa
Mugihe ubushakashatsi mubijyanye na fosifolipide bukomeje gutera imbere, hari ingaruka nyinshi kubushakashatsi buzaza no gukoresha inganda. Ubwa mbere, ubushakashatsi burenzeho kubijyanye numutekano, gukora neza, hamwe nubufatanye bushobora kuba hagati ya fosifolipide nibindi bikoresho bishobora gutanga inzira yiterambere ryibicuruzwa byinshi bishya byita kubikenerwa byabaguzi. Byongeye kandi, ubushakashatsi ku ikoreshwa rya fosifolipide mu mbuga z’ikoranabuhanga zigenda zigaragara nka nanoemuliyoni, nanocarrier zishingiye kuri lipide, hamwe na lipide-polymer nanoparticles itanga amasezerano yo kongera bioavailability no gutanga intego yo gutanga ibinyabuzima bikomoka ku biribwa, kwisiga, na farumasi. Ubu bushakashatsi bushobora kuganisha ku gushiraho ibicuruzwa bishya bitanga imikorere inoze.
Duhereye ku nganda, akamaro ka fosifolipide mu bikorwa bitandukanye bishimangira akamaro ko guhanga udushya no gufatanya mu nganda no mu nganda. Hamwe nogukenera ibintu bisanzwe nibikorwa, guhuza fosifolipide mubiribwa, kwisiga, hamwe na farumasi bitanga amahirwe kumasosiyete yo guteza imbere ibicuruzwa byujuje ubuziranenge, birambye bihuza nibyifuzo byabaguzi. Byongeye kandi, ejo hazaza hifashishijwe inganda za fosifolipide zishobora kuba zirimo ubufatanye bw’inzego, aho ubumenyi n’ikoranabuhanga biva mu biribwa, amavuta yo kwisiga, n’inganda zikoreshwa mu bya farumasi bishobora guhanahana amakuru kugira ngo habeho ibicuruzwa bishya, byinshi bikora bitanga ubuzima bwiza n’ubwiza.
Mu gusoza, uburyo bwinshi bwa fosifolipide nakamaro kayo mubiribwa, kwisiga, hamwe na farumasi bituma bakora ibintu byinshi mubicuruzwa byinshi. Ubushobozi bwabo mubushakashatsi buzaza hamwe nibikorwa byinganda biratanga inzira yo gukomeza gutera imbere mubintu byinshi ndetse no guhanga udushya, bigahindura imiterere yisoko ryisi yose mubikorwa bitandukanye.
Reba:
1. Mozafari, MR, Johnson, C., Hatziantoniou, S., & Demetzos, C. (2008). Nanoliposomes nibisabwa mubiribwa nanotehnologiya. Ikinyamakuru cy'ubushakashatsi bwa Liposome, 18 (4), 309-327.
2. Mezei, M., & Gulasekharam, V. (1980). Liposomes - Sisitemu yatoranijwe yo gutanga imiti yinzira yubuyobozi. Ifishi ya dosiye. Ubumenyi bwubuzima, 26 (18), 1473-1477.
3. Williams, AC, & Barry, BW (2004). Abongera imbaraga. Isuzuma ryiza ryo gutanga ibiyobyabwenge, 56 (4), 603-618.
4. Arouri, A., & Mouritsen, OG (2013). Fosifolipide: ibibaho, ibinyabuzima nisesengura. Igitabo cya hydrocolloide (Inyandiko ya kabiri), 94-123.
5. Berton-Carabin, CC, Ropers, MH, Genot, C., & Lipid Emulsions n'imiterere yabyo - Ikinyamakuru cy'ubushakashatsi bwa Lipid. (2014). kwigana ibintu bya fosifolipide yo mu rwego rwo hejuru. Ikinyamakuru cy'ubushakashatsi bwa Lipid, 55 (6), 1197-1211.
6. Wang, C., Zhou, J., Wang, S., Li, Y., Li, J., & Deng, Y. (2020). Inyungu zubuzima hamwe nogukoresha fosifolipide karemano mubiryo: Isubiramo. Ubumenyi bushya bwibiryo byubumenyi & Emerging Technologies, 102306. 8. Blezinger, P., & Harper, L. (2005). Fosifolipide mu biryo bikora. Mu Guhindura Indyo Yerekana Inzira Yerekana Inzira (pp. 161-175). Itangazamakuru rya CRC.
7. Frankenfeld, BJ, & Weiss, J. (2012). Fosifolipide mu biryo. Muri Fosifolipide: Ibiranga, Metabolism, hamwe na Biologiya ikoreshwa (pp. 159-173). Itangazamakuru rya AOCS. 7. Hughes, AB, & Baxter, NJ (1999). Emulisingi ya fosifolipide. Mu biryo byokurya hamwe nifuro (pp. 115-132). Umuryango wibwami wa chimie
8. Lopes, LB, & Bentley, MVLB (2011). Fosifolipide muri sisitemu yo gutanga amavuta yo kwisiga: gushakisha ibyiza biva muri kamere. Muri Nanocosmetics na nanomedicines. Springer, Berlin, Heidelberg.
9. Schmid, D. (2014). Uruhare rwa fosifolipide karemano muburyo bwo kwisiga no kwita kubantu. Iterambere mu bumenyi bwo kwisiga (pp. 245-256). Gusuka, Cham.
10. Jenning, V., & Gohla, SH (2000). Encapsulation ya retinoide muri lipide ikomeye ya nanoparticles (SLN). Ikinyamakuru cya Microencapsulation, 17 (5), 577-588. 5. Rukavina, Z., Chiari, A., & Schubert, R. (2011). Kunoza amavuta yo kwisiga ukoresheje liposomes. Muri Nanocosmetics na nanomedicines. Springer, Berlin, Heidelberg.
11. Neubert, RHH, Schneider, M., & Kutkowska, J. (2005). Fosifolipide mu kwisiga no gutunganya imiti. Muri Kurwanya Gusaza muri Ophthalmology (p. 55-69). Springer, Berlin, Heidelberg. 6. Bottari, S., Freitas, RCD, Villa, RD, & Senger, AEVG (2015). Ikoreshwa ryibanze rya fosifolipide: ingamba zitanga ikizere cyo gusana inzitizi yuruhu. Igishushanyo mbonera cya farumasi, 21 (29), 4331-4338.
12. Torchilin, V. (2005). Igitabo cya farumasi yingenzi, imiti ya farumasi na metabolisme yibiyobyabwenge kubashakashatsi mu nganda. Ubumenyi bwa Springer & Itangazamakuru ryubucuruzi.
13. Itariki, AA, & Nagarsenker, M. (2008). Gushushanya no gusuzuma kwigenga - emulisitiya yo gutanga ibiyobyabwenge (SEDDS) ya nimodipine. AAPS PharmSciTech, 9 (1), 191-196.
2. Allen, TM, & Cullis, PR (2013). Sisitemu yo gutanga imiti ya Liposomal: Kuva mubitekerezo kugeza mubikorwa byubuvuzi. Isuzuma ryo Gutanga Ibiyobyabwenge Byambere, 65 (1), 36-48. 5. Bozzuto, G., & Molinari, A. (2015). Liposomes nkibikoresho bya nanomedical. Ikinyamakuru mpuzamahanga cya Nanomedicine, 10, 975.
Lichtenberg, D., & Barenholz, Y. (1989). Imiti ya Liposome ikora neza: icyitegererezo cyakazi no kugenzura ubushakashatsi. Gutanga ibiyobyabwenge, 303-309. 6. Simoni, K., & Vaz, WLC (2004). Sisitemu yicyitegererezo, lipid rafts, hamwe na selile. Buri mwaka Isubiramo rya Biofiziki nuburyo bwa Biomolecular, 33 (1), 269-295.
Williams, AC, & Barry, BW (2012). Abongera imbaraga. Muburyo bwa Dermatologiya: Absorption Percutaneous (pp. 283-314). Itangazamakuru rya CRC.
Muller, RH, Radtke, M., & Wissing, SA (2002). Nanoparticles ikomeye ya lipide (SLN) hamwe na nanostructures itwara lipide (NLC) mugutegura kwisiga na dermatologiya. Isuzuma ryo Gutanga Ibiyobyabwenge Byambere, 54, S131-S155.
2. Severino, P., Andreani, T., Makedo, AS, Fangueiro, JF, Santana, MHA, & Silva, AM (2018). Ibigezweho kandi bigezweho kuri lipid nanoparticles (SLN na NLC) kugirango itange imiti mu kanwa. Ikinyamakuru cyo gutanga ibiyobyabwenge Ubumenyi n'ikoranabuhanga, 44, 353-368. 5. Torchilin, V. (2005). Igitabo cya farumasi yingenzi, imiti ya farumasi na metabolisme yibiyobyabwenge kubashakashatsi mu nganda. Ubumenyi bwa Springer & Itangazamakuru ryubucuruzi.
3. Williams, KJ, & Kelley, RL (2018). Uruganda rukora imiti y’ibinyabuzima. John Wiley & Abahungu. 6. Simoni, K., & Vaz, WLC (2004). Sisitemu yicyitegererezo, lipid rafts, hamwe na selile. Buri mwaka Isubiramo rya Biofiziki nuburyo bwa Biomolecular, 33 (1), 269-295.
Igihe cyo kohereza: Ukuboza-27-2023
